NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

DocLee, Thanks for that insight and information about vaccines and potential of DCVax there.

My hypothesis was modest, thinking only of the overlaps of cancer epitopes. That it creates a prophylactic effect against a potential second primary cancer, and that would be an important by-product or benefit to cancer patients that use DCVax to treat their initial primary cancer, that may be overlooked today. But I think you are saying there is a potential market opportunity here as well.

With Dr Bosch's observation that there is a considerable overlap of malignant epitopes between various unrelated malignancies, a potential new realm of prophylaxis (ie "true" vaccination) opens up. This would be the prevention (by vaccination) of many/most/all malignant diseases using a simple extension of the the DCVax method which for the mid-term future would be the only way of achieving this end.

Let me emphasize that point: a vaccination against cancers. I think that is major. Thanks again. I think over time, more opportunities we have never thought of before will emerge with this versatile DCVax technology platform.

Sorry if I repeat this too often, but NWBO is a UNICORN COMPANY and by definition will disrupt existing markets and open up a greenfield of new undiscovered ones.